⌕
Regeneron Pharmaceuticals · REGN · Nasdaq
Tenet 64 · Solid
Compare
$956.05+0.06%Market openTenet 64 · Solid
$956.05+0.58 (+0.06%)
Market open · as of 2:21 PM ET· Nasdaq · USD

Regeneron Pharmaceuticals (REGN) Stock Splits

Splits, dividend moves, buybacks and structural changes on file for REGN, and what each one says about how management treats you, the shareholder.

Sources Dividend announcements and company filings Dividends and filingsHow we compute thisNot investment advice
•
Management posture
Returns cash, still building a record

Management returns cash through dividends and/or buybacks, but the track record is shorter or less consistent than a seasoned compounder's. Judge each action on its own coverage.

Annual raise streak
—
steady payer, no raise streak on record
Buyback · FY25
$3.4B
repurchased, latest FY
Last split
None
no splits on file
Delist / distress
None
no red flags on file
Reads are interpretationsEach action's read is Tenet's plain-English interpretation of the action type: a starting point, not investment advice.

Reads are Tenet's plain-English interpretation of each action type, a starting point, not investment advice.

How much stock did Regeneron Pharmaceuticals buy back last fiscal year?

Regeneron Pharmaceuticals repurchased $3.4B of its own shares in fiscal 2025.

When did Regeneron Pharmaceuticals last raise its dividend?

Regeneron Pharmaceuticals' last dividend increase was +6.8%, with an ex-dividend date of Feb 20, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.